vTv Therapeutics (VTVT) EBT Margin (2016 - 2025)
Historic EBT Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 26100.0%.
- vTv Therapeutics' EBT Margin changed N/A to 26100.0% in Q4 2024 from the same period last year, while for Sep 2025 it was 166935.29%, marking a year-over-year decrease of 1646743900.0%. This contributed to the annual value of 2222.71% for FY2024, which is N/A changed from last year.
- vTv Therapeutics' EBT Margin amounted to 26100.0% in Q4 2024.
- Over the past 5 years, vTv Therapeutics' EBT Margin peaked at 25.11% during Q4 2020, and registered a low of 105366.67% during Q4 2021.
- Its 4-year average for EBT Margin is 31446.3%, with a median of 17722.22% in 2021.
- In the last 5 years, vTv Therapeutics' EBT Margin soared by 983394000bps in 2020 and then tumbled by -1053917800bps in 2021.
- vTv Therapeutics' EBT Margin (Quarter) stood at 25.11% in 2020, then plummeted by -419665bps to 105366.67% in 2021, then soared by 36bps to 67666.67% in 2022, then surged by 61bps to 26100.0% in 2024.
- Its EBT Margin stands at 26100.0% for Q4 2024, versus 591.9% for Q1 2024 and 67666.67% for Q4 2022.